Bumrungrad Hospital PCL (BKK:BH)
Thailand · Delayed Price · Currency is THB 190.50
-3.50 (-1.80%)
At close: Feb 20, 2026
Bumrungrad Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 25,215 | 25,718 | 25,376 | 20,721 | 12,460 |
Other Revenue | 233.86 | 144.87 | 170.76 | 186.97 | 144.1 |
| 25,449 | 25,862 | 25,547 | 20,908 | 12,605 | |
Revenue Growth (YoY) | -1.60% | 1.23% | 22.19% | 65.87% | 1.32% |
Cost of Revenue | 12,151 | 12,503 | 12,895 | 11,099 | 7,731 |
Gross Profit | 13,298 | 13,359 | 12,652 | 9,808 | 4,874 |
Selling, General & Admin | 4,202 | 4,171 | 4,180 | 3,798 | 3,296 |
Operating Expenses | 4,202 | 4,171 | 4,180 | 3,798 | 3,296 |
Operating Income | 9,096 | 9,188 | 8,472 | 6,010 | 1,578 |
Interest Expense | -6.63 | -8.33 | -2.39 | -3.55 | -119.76 |
Interest & Investment Income | - | 279.47 | 140.95 | 45.95 | 68.78 |
Earnings From Equity Investments | -0.88 | -0.43 | -0.9 | -0.51 | -68.87 |
Currency Exchange Gain (Loss) | -14.2 | -22.73 | 28.06 | -3.27 | -1.91 |
Other Non Operating Income (Expenses) | 226.68 | - | - | - | - |
Pretax Income | 9,301 | 9,436 | 8,638 | 6,049 | 1,456 |
Income Tax Expense | 1,737 | 1,604 | 1,583 | 1,072 | 215.85 |
Earnings From Continuing Operations | 7,564 | 7,832 | 7,055 | 4,977 | 1,240 |
Minority Interest in Earnings | -51.96 | -57.33 | -48.68 | -38.54 | -24.35 |
Net Income | 7,512 | 7,775 | 7,006 | 4,938 | 1,216 |
Net Income to Common | 7,512 | 7,775 | 7,006 | 4,938 | 1,216 |
Net Income Growth | -3.38% | 10.96% | 41.88% | 306.21% | 0.96% |
Shares Outstanding (Basic) | 795 | 795 | 795 | 795 | 795 |
Shares Outstanding (Diluted) | 867 | 867 | 867 | 867 | 867 |
Shares Change (YoY) | -0.00% | - | - | - | - |
EPS (Basic) | 9.45 | 9.78 | 8.81 | 6.21 | 1.53 |
EPS (Diluted) | 8.66 | 8.96 | 8.08 | 5.69 | 1.40 |
EPS Growth | -3.35% | 10.89% | 42.00% | 306.43% | 0.72% |
Free Cash Flow | 6,333 | 7,455 | 5,522 | 5,067 | 2,753 |
Free Cash Flow Per Share | 7.30 | 8.59 | 6.37 | 5.84 | 3.17 |
Dividend Per Share | - | 5.000 | 4.500 | 3.500 | 3.200 |
Dividend Growth | - | 11.11% | 28.57% | 9.38% | - |
Gross Margin | 52.25% | 51.66% | 49.53% | 46.91% | 38.66% |
Operating Margin | 35.74% | 35.53% | 33.16% | 28.75% | 12.52% |
Profit Margin | 29.52% | 30.06% | 27.43% | 23.62% | 9.64% |
Free Cash Flow Margin | 24.88% | 28.82% | 21.62% | 24.23% | 21.84% |
EBITDA | 10,164 | 10,115 | 9,405 | 6,938 | 2,553 |
EBITDA Margin | 39.94% | 39.11% | 36.81% | 33.18% | 20.26% |
D&A For EBITDA | 1,068 | 927.23 | 933.08 | 927.49 | 975.86 |
EBIT | 9,096 | 9,188 | 8,472 | 6,010 | 1,578 |
EBIT Margin | 35.74% | 35.53% | 33.16% | 28.75% | 12.52% |
Effective Tax Rate | 18.68% | 17.00% | 18.32% | 17.72% | 14.83% |
Revenue as Reported | 25,449 | 25,862 | 25,575 | 20,908 | 12,605 |
Advertising Expenses | - | 537.6 | 494.86 | 414.75 | 233.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.